Literature DB >> 2176202

Prevalence of human papillomavirus types 16 and 18 in cervical carcinomas: a study by dot and Southern blot hybridization and the polymerase chain reaction.

S H Low1, T W Thong, T H Ho, Y S Lee, T Morita, M Singh, E H Yap, Y C Chan.   

Abstract

Histologically classified biopsies from 83 women with invasive cervical carcinoma were analyzed by dot blot hybridization for human papillomavirus (HPV) types 16 and 18 infection. Sixty of the 83 (72.3%) were found to contain HPV DNA, of which 43 (51.8%) contained HPV 16 DNA, 12 (14.5%) contained HPV 18 DNA and 5 (6.0%) contained both HPV 16 and 18 DNAs. Southern blot analysis on 65 specimens gave similar results. Of 23 specimens negative by dot blot, 21 were tested by the polymerase chain reaction. Seventeen of the 21 were positive for HPV DNA, of which 13 contained HPV 16 DNA and 4 contained both HPV 16 and 18 DNAs. In all, 95.1% (77/81) were positive for HPV 16 and/or 18 DNA sequences.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2176202      PMCID: PMC5917980          DOI: 10.1111/j.1349-7006.1990.tb02522.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  35 in total

1.  Symptomatic and asymptomatic cervical infections with human papillomavirus during pregnancy.

Authors:  K H Fife; R E Rogers; B W Zwickl
Journal:  J Infect Dis       Date:  1987-12       Impact factor: 5.226

2.  Human papillomavirus DNA in normal, metaplastic, preneoplastic and neoplastic epithelia of the cervix uteri.

Authors:  P G Fuchs; F Girardi; H Pfister
Journal:  Int J Cancer       Date:  1988-01-15       Impact factor: 7.396

3.  Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia.

Authors:  R K Saiki; S Scharf; F Faloona; K B Mullis; G T Horn; H A Erlich; N Arnheim
Journal:  Science       Date:  1985-12-20       Impact factor: 47.728

4.  Papillomavirus DNA in cervical carcinoma specimens from central China.

Authors:  X Xiao; M Cao; T R Miller; Z Y Cao; T S Yen
Journal:  Lancet       Date:  1988-10-15       Impact factor: 79.321

5.  Prevalence of human papillomavirus type 16 DNA in cervical carcinoma samples in East Anglia.

Authors:  S M Scholl; E M Pillers; R E Robinson; P J Farrell
Journal:  Int J Cancer       Date:  1985-02-15       Impact factor: 7.396

6.  Histological types of carcinoma of the uterine cervix and the detectability of human papillomavirus DNA.

Authors:  M Fukushima; T Okagaki; L B Twiggs; B A Clark; K R Zachow; R S Ostrow; A J Faras
Journal:  Cancer Res       Date:  1985-07       Impact factor: 12.701

7.  Human papillomavirus type 16 DNA in genital tumours: a pathological and molecular analysis.

Authors:  D Di Luca; S Pilotti; B Stefanon; A Rotola; P Monini; M Tognon; G De Palo; F Rilke; E Cassai
Journal:  J Gen Virol       Date:  1986-03       Impact factor: 3.891

8.  Detection of cytomegalovirus in urine from newborns by using polymerase chain reaction DNA amplification.

Authors:  G J Demmler; G J Buffone; C M Schimbor; R A May
Journal:  J Infect Dis       Date:  1988-12       Impact factor: 5.226

9.  Human papillomavirus infections in women with and without abnormal cervical cytology.

Authors:  E M de Villiers; D Wagner; A Schneider; H Wesch; H Miklaw; J Wahrendorf; U Papendick; H zur Hausen
Journal:  Lancet       Date:  1987-09-26       Impact factor: 79.321

10.  Detection of human papilloma virus in paraffin-embedded tissue using the polymerase chain reaction.

Authors:  D K Shibata; N Arnheim; W J Martin
Journal:  J Exp Med       Date:  1988-01-01       Impact factor: 14.307

View more
  6 in total

1.  Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus.

Authors:  B Kleter; L J van Doorn; L Schrauwen; A Molijn; S Sastrowijoto; J ter Schegget; J Lindeman; B ter Harmsel; M Burger; W Quint
Journal:  J Clin Microbiol       Date:  1999-08       Impact factor: 5.948

2.  Comparison between the Hybrid Capture II Test and an SPF1/GP6+ PCR-based assay for detection of human papillomavirus DNA in cervical swab samples.

Authors:  Shang-Lang Huang; Angel Chao; Swei Hsueh; Fang-Yu Chao; Chu-Chun Huang; Jung-Erh Yang; Ching-Yu Lin; Chiu-Cho Yan; Hung-Hsueh Chou; Kuan-Gen Huang; Huei-Jean Huang; Tzu-I Wu; Mao-Jung Tseng; Jian-Tai Qiu; Cheng-Tao Lin; Ting-Chang Chang; Chyong-Huey Lai
Journal:  J Clin Microbiol       Date:  2006-05       Impact factor: 5.948

3.  Comparison of Virapap filter hybridization with polymerase chain reaction and Southern blot hybridization methods for detection of human papillomavirus in tonsillar and pharyngeal cancers.

Authors:  S Watanabe; H Ogura; K Fukushima; Y Yabe
Journal:  Eur Arch Otorhinolaryngol       Date:  1993       Impact factor: 2.503

4.  Serum antibodies to Trichomonas vaginalis in invasive cervical cancer patients.

Authors:  E H Yap; T H Ho; Y C Chan; T W Thong; G C Ng; L C Ho; M Singh
Journal:  Genitourin Med       Date:  1995-12

5.  Association between human Papillomavirus and colorectal adenocarcinoma and its influence on tumor staging and degree of cell differentiation.

Authors:  Olavo Magalhães Picanço-Junior; Andre Luiz Torres Oliveira; Lucia Thereza Mascarenhas Freire; Rosangela Baia Brito; Luisa Lina Villa; Délcio Matos
Journal:  Arq Bras Cir Dig       Date:  2014 Jul-Sep

6.  High-resolution melting molecular signatures for rapid identification of human papillomavirus genotypes.

Authors:  Ta-Hsien Lee; Tzong-Shoon Wu; Ching-Ping Tseng; Jiantai Timothy Qiu
Journal:  PLoS One       Date:  2012-08-20       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.